Hydrothermally processed 1D hydroxyapatite: Mechanism of formation and biocompatibility studies by Stojanović, Zoran S. et al.
Hydrothermally processed 1D hydroxyapatite: mechanism of 
formation and biocompatibility studies
Zoran S. Stojanović1, Nenad Ignjatović1, Victoria Wu2, Vojka Žunič3, Ljiljana Veselinović1, 
Srečo Škapin3, Miroslav Miljković4, Vuk Uskoković2,5, and Dragan Uskoković1,*
1Centre for Fine Particles Processing and Nanotechnologies, Institute of Technical Sciences of 
the Serbian Academy of Sciences and Arts, Knez Mihailova 35/4, 11000 Belgrade, Serbia
2Advanced Materials and Nanobiotechnology Laboratory, Department of Bioengineering, 
University of Illinois, 851 South Morgan Street, Chicago, IL 60607-7052, USA
3Advanced Materials Department, Joţef Stefan Institute, Jamova cesta 39, 1000 Ljubljana, 
Slovenia
4Laboratory for Electron Microscopy, Faculty of Medicine University of Niš, Dr. Zoran Đinđić 
Boulevard 81, 18 000 Niš, Serbia
5Department of Biomedical and Pharmaceutical Sciences, School of Pharmacy, Chapman 
University, 9401 Jeronimo Road, Irvine, CA 92618-1908, USA
Abstract
Recent developments in bone tissue engineering have led to an increased interest in one-
dimensional (1D) hydroxyapatite (HA) nano- and micro-structures such as wires, ribbons and 
tubes. They have been proposed for use as cell substrates, reinforcing phases in composites and 
carriers for biologically active substances. Here we demonstrate the synthesis of 1D HA structures 
using an optimized, urea-assisted, high-yield hydrothermal batch process. The one-pot process, 
yielding HA structures composed of bundles of ribbons and wires, was typified by the 
simultaneous occurrence of a multitude of intermediate reactions, failing to meet the uniformity 
criteria over particle morphology and size. To overcome these issues, the preparation procedure 
was divided to two stages: dicalcium phosphate platelets synthesized in the first step were used as 
a precursor for the synthesis of 1D HA in the second stage. Despite the elongated particle 
morphologies, both the precursor and the final product exhibited excellent biocompatibility and 
caused no reduction of viability when tested against osteoblastic MC3T3-E1 cells in 2D culture up 
to the concentration of 2.6 mg/cm2. X-ray powder diffraction combined with a range of electron 
microscopies and laser diffraction analyses was used to elucidate the formation mechanism and the 
microstructure of the final particles. The two-step synthesis involved a more direct transformation 
of DCP to 1D HA with the average diameter of 37 nm and the aspect ratio exceeding 100:1. The 
comparison of crystalline domain sizes along different crystallographic directions showed no signs 
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of significant anisotropy, while indicating that individual nanowires are ordered in bundles in the b 
crystallographic direction of the P63/m space group of HA. Intermediate processes, e.g., 
dehydration of dicalcium phosphate, are critical for the formation of 1D HA alongside other key 
aspects of this phase transformation, it must be investigated in more detail in the continuous 
design of smart HA micro- and nano-structures with advanced therapeutic potentials.
Keywords
hydrothermal; nanowires; hydroxyapatite; biomedical; particle size distribution
1. Introduction
The most prospective biocomposites in bone tissue engineering are the combinations of (a) 
natural biopolymers as the macroporous matrix phase and (b) inorganic, organic or hybrid 
nano- and micro-structures as the reinforcement phase [1–5]. Being the natural bone mineral 
phase and being known for an array of properties that favor bone tissue regeneration, 
ranging from biocompatibility to osteoconductivity to non-immunogenicity, hydroxyapatite 
(HA) is the natural material of choice for the reinforcement phase of biocomposites, rivaled 
in response only by a handful of other biomaterials, such as bioactive glass [6], chitin [7], 
carbon/graphene-based nanostructures [8,9], and a few others. A special interest in bone 
tissue engineering has been directed to nanoparticulate and nanostructured HA with large 
surface–area–to–volume ratios [10]. Osteoconductivity of the material containing such 
nanostructures is directly dependent on their specific surface area [11], which also favors the 
high loading capacity with respect to various biologically active substances, given that 
adsorption presents the sole mechanism of drug loading when it comes to HA. One-
dimensional HA nano- and micro-structures for potential biomedical applications, such as 
tubes [12,13], wires [14], rods [15–17], ribbons [18] and similar, morphological porous and 
hierarchically assembled 3D varieties, are especially good candidates to fulfill these two 
demands. The combined effects of nano- and micro-sized surfaces in 1D HA materials could 
not only be optimal for cell proliferation and osteogenic differentiation, but also beneficial 
for the expression of angiogenetic factors in stem cell differentiation [19]. The development 
of procedures for controlled synthesis of 1D HA nanostructures is mainly driven by this 
goal, especially since the recent progress in this field still does not entirely meet the criteria 
for effective control over size and shape.
The first goal of this study was to successfully synthesize uniform 1D HA structures, 
ranging from micro- and nano-wires to micro- and nano-tubes to more complex 
morphological varieties, using a hydrothermal batch process on the gram scale. The 
framework for the synthesis was adopted by studying the traditional hydrothermal and 
solvothermal methods for the synthesis of 1D HA structures such as whiskers, ribbons, 
platelets and tubes [18,20–24] and organic modifiers assisted HA synthesis methods [25–
27]. A detailed structural characterization of different intermediates and products of the 
method developed herein was then used to clarify the mechanism of the formation of 1D 
structures. By examining previous studies concerning the mechanism of 1D HA formation, 
we have divided the initially developed one-pot procedure into two stages to achieve a better 
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control over the product properties. Finally, since uniaxial growth is often accompanied by 
the less favorable particle/cell interface, biological assays were conducted to assess the 
cytotoxicity and biocompatibility of the synthesized particles in an in vitro setting.
2. Experimental details
2.1. Preparation of HA samples by synthesis path I
Two synthesis paths were investigated and a two-liter Parr hydrothermal reactor was used in 
both of them (Fig. 1). The first path was a single-stage, so-called one-pot preparation 
method involving (a) the precipitation of calcium and phosphate ions into dicalcium 
phosphate dihydrate (DCPD, aka brushite) with the addition of urea, and (b) a subsequent 
hydrothermal treatment of the resulting slurry. More specifically, 400 ml 0.12 M calcium 
acetate solution in water (Ca(CH3COO)2·H2O, Mw=158.17 g/mol, 99 %, Acros Organics, 
Belgium) was added slowly (100 ml/h) to 400 ml 0.1 M solution of ammonium phosphate 
monobasic (NH4H2PO4, Mw=115.03 g/mol, > 98 %, VWR International, USA), under 
strong mixing. pH value of the suspension following the addition of calcium acetate was 4.5. 
After mixing, 200 ml 0.6 M urea ((NH2)2CO, Mw=60.06, 99 %, Centrohem, Serbia) was 
added tothe dispersion and no pH change was detected. The 2 L PTFE liner in which this 
suspension had been made was then placed into a 2 L stainless steel cylinder of a Parr 
hydrothermal reactor and sealed for the hydrothermal treatment. The synthesis parameters 
are summarized in Table 1. All syntheses were run at 120 °C and ~ 7 bar pressure without 
mixing. The varied parameters were Ca/P molar ratio (via reducing the Ca content), the 
hydrothermal reaction time, and polyvinylpyrrolidone (PVP, K30, Mw=40,000 Da, Fluka 
AG, Switzerland) addition.
2.2. Preparation of HA samples by synthesis path II
The second path was composed of two stages and was designed to achieve a better control of 
1D HA structures and help us gain a better insight into the mechanism of 1D HA formation. 
The first stage included the preparation of a calcium oleate complex and the precipitation of 
dicalcium phosphate anhydrous (DCPA, aka monetite) platelets. This precursor was then 
dried (or used freshly prepared) and hydrothermally treated in the second stage.
More specifically, calcium oleate complex was formed by adding 200 ml 0.25 M water – 
ethanol (3:7) solution of sodium oleate (CH3(CH2)7CH=CH(CH2)7COONa, Mw=304.44 g/
mol, ≥ 82 % oleic acid content, Sigma – Aldrich, Germany) in 200 ml 0.125 M aqueous 
solution of calcium – nitrate (Ca(NO3)2·4H2O, Mw=236.15 g/mol, ≥ 98 %, Sigma – Aldrich, 
Germany). Precipitated calcium oleate, a white sticky substance, was separated by decanting 
the liquid phase and immediately transferred to a 300 ml flask containing 200 ml water – 
ethanol (≈ 1:1) solution of ammonium phosphate monobasic (NH4H2PO4, Mw=115.03 g/
mol, > 98 %, VWR International, USA). Ca/P molar ratio in this stage was set to 0.5. The 
flask was then heated and brought to boiling in reflux for 5 h total. The hydrothermal 
precursor for Samples 7 and 8 was prepared with the addition of N,N–dimethylformamide 
(DMF) (HCON(CH3)2, Mw=73.10 g/mol, ≥ 98 %, Reanal, Hungary) into the flask three 
hours into the boiling process. After the completion of the reaction and cooling, the liquid 
phase was decanted and the products were repeatedly washed with ethanol, centrifuged, and 
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left to dry at 60°C overnight. The dried products were placed into a PTFE liner and 
dispersed by mechanical mixing in 1 L of 0.12 M urea solution. The hydrothermal reaction 
was run at 120 °C and 7 bars for 96 h without mixing. The synthesis parameters used in the 
making of the DCPA precursor and in the subsequent hydrothermal treatment are 
summarized in Table 2.
After the synthesis, the products were collected from the bottom of the liner and washed 
with distilled water and centrifuged numerous times. The washing of the samples was 
finished at the point when pH of the supernatant was ~ 5.5. The products were then dried for 
24 h in an oven at 60 °C. The amount of calcium used in both synthesis routes was the same, 
and the mass of the dried products (yield) in each hydrothermal batch was near the 
theoretically calculated relative to the calcium content, e.g., 4.5 g for Sample2.
2.3. Characterization of samples
The precursors and products were characterized using X–ray powder diffraction (XRD, 
Philips PW1050 diffractometer with CuKα1,2 radiation), a scanning electron microscope 
(SEM, JEOL JSM 5300), a field-emission SEM (FE – SEM, ULTRA plus, Carl Zeiss) 
equipped with an energy-dispersive spectrometer (EDS, Inca 400, Oxford Instruments), a 
transmission electron microscope (JEM-2100, JEOL Inc., Tokyo, Japan ), operating at 200 
kV and equipped with a slow-scan CCD camera ORIUS SC1000A (Gatan Ltd.), an optical 
microscope (B-500MET with Optikam Pro 5LT digital camera, Optika, Italy) and laser 
diffraction analyzer (LD, Mastersizer 2000, Malvern Instruments). The ethanol suspensions 
of dried precursors and samples used for optical imaging were sonicated for 2 min and 
deposited as droplets on slides. Aqueous or ethanol suspensions of dried samples were used 
for the LD analysis, depending on the dispersibility of precursors and samples.
FTIR spectra were recorded using the KBr pellet technique at the room temperature on a 
Nicolet FT-IR 5700 spectrometer (Thermo Electron Corporation, USA) over the 4000–500 
cm−1 wave number range, with 2 cm−1 resolution. Mixtools software package in R 
programming language was used to fit XRD and particle size distribution data. The size 
distribution of elongated particles, 1D and 2D structures, analyzed by LD methods appeared 
as a mixture of Gaussian distributions [28,29], i.e. a multimodal distribution. The function 
normalmixEM (expectation maximization algorithm) was used to fit the mixtures of 
univariate normals. To check how good the fit was, the Kolmogorov – Smirnov test was 
performed using an R function ks.test. The sample code, results and cumulative distributions 
of experimental and fitted data for DCP platelets are given in the supplementary section. The 
distributions were fitted with 2 or 3 Gaussians. The average diameters and aspect ratios of 
the synthesized nanowires (n = 91) were determined as a part of the image analysis 
performed using ImageJ software (National Institutes of Health, Bethesda, MD).
2.4. Cytotoxicity tests
Mouse calvarial pre-osteoblastic cell line, MC3T3-E1 subclone 4, was purchased from 
American Tissue Culture Collection (ATCC, Rockville, MD) and cultured in Alpha 
Minimum Essential Medium (α-MEM; Gibco) supplemented with 10% fetal bovine serum 
(FBS, Invitrogen) and containing no ascorbic acid. The medium was replaced every 48 h, 
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and the cultures were incubated at 37 °C in a humidified atmosphere containing 5% CO2. 
Every 7 days, the cells were detached from the surface of the 75 cm2 cell culture flask 
(Greiner Bio-One) using 0.25 wt% trypsin/EDTA, washed, centrifuged (3000 rpm × 5 min), 
resuspended in 10 ml media and subcultured in 1:10 volume ratio. To determine if the 
nanoparticles exhibited cytotoxic effects, MC3T3-E1 cells were seeded at 5 × 105 cells/well 
in 24-well plates and differentiated into the osteoblastic lineage for 14 days with 100 μg/ml 
of ascorbic acid as the chemical differentiation agent dissolved in α-MEM and in the 
presence of either 1 or 5 mg/well of nanoparticles. Cell viability was determined after 14 
days of incubation using the Vybrant MTT cell proliferation assay (Molecular Probes) and 
following the manufacturer’s instructions. Absorbance was read at 570 nm on a UV/Vis 
spectrophotometric microplate reader (BGM Labtech, FLUostar Omega). To examine the 
interaction between cells and nanoparticles, immunohistochemistry staining was done after 7 
days of differentiation in the presence of nanoparticles. The 5 × 105 cells/well were seeded 
on glass coverslips, washed with phosphate buffer saline (PBS), and fixed for 5 minutes in 
4% paraformaldehyde. Cells were then washed with PBS and incubated with Alexa Fluor 
568 Phalloidin (1:400) (Molecular Probes) and OsteoImage™ bone mineralization staining 
agent (Lonza) for 30 minutes. Cells were then washed 3 times with PBS and cell nuclei were 
counterstained using NucBlue fixed cell ReadyProbe reagent (Molecular Probes) for 20 
minutes. Images were obtained using a Zeiss LSM 710 confocal microscope (UIC core 
imaging facility). All the samples were analyzed in triplicates.
3. Results and discussion
3.1 One pot synthesis of HA nanowires and plates bundles
Preparation of the right precursors is the first and often the most crucial segment of the 
hydrothermal synthesis of fine powders. Due to the wide window of chemical parameters 
available for control in this stage (salts, complexes, hydroxides, oxides, solvents, et cetera), 
various combinations thereof are possible, each leading to a potentially unique product of 
the hydrothermal process [30]. The preparation of the precursor calcium phosphate 
precipitates, schematized in Fig. 1(a), carried out in an acidic medium (pH ≈ 4.5) and at 
room temperature, in the first synthesis method led to the formation of dicalcium phosphate 
dehydrate (DCPD) [31,32], a white flaky precipitate, and could be represented with the 
following equation:
With the molar ratio of Ca/P being ≥ 1 (Table 1), H2PO4− ions are expected to be fully 
consumed in the process, whereas the release of protons entailing the precipitation reaction 
leads to a drop in the pH, down to ~ 4.5. The concentration of OH− ions, i.e. pH, is, in fact, 
critical for tuning the composition and morphology of calcium phosphates [32]. During the 
treatment, until its complete decomposition, urea provides a source for the steady release of 
OH− ions and CO2 at temperatures above 80 °C [21,33]. At the onset of the decomposition, 
OH− ions are mostly neutralized by the free protons, which leads to the crystallization of 
either DCPD or anhydrous dicalcium phosphate (DCPA), depending on the temperature used 
[32,34]. Regardless of the chemical composition, crystal hydrates form at lower 
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temperatures compared to their anhydrous allotropes. This is the result of the large energy 
barrier associated with the dehydration process. DCPD, consequently, forms at lower 
temperatures, e.g. 50 °C and pH 5, and has a feathery appearance [32]. In contrast, DCPA 
and DCPD/DCPA mixtures form at higher temperatures and with different morphologies, 
typically appearing in form of thicker, micrometric plates [34,35]. The formation of DCPA 
via dehydration in the hydrothermal solution can be represented as:
Upon the complete consumption of protons from the solution, the concentration of OH− ions 
starts to gradually increase and their reaction with DCPD starts, yielding water in the 
conversion process. Eventually, if prolonged enough, subjugation to the attack of OH− ions 
leads to the dissolution of DCP and recrystallization of HA via a dissolution–
recrystallization mechanism representable by the following equations:
The formation of HA can occur either subsequently, following the dissolution of DCP, or 
simultaneously, depending on the kinetic conditions under which urea decomposes:
Results of the XRD phase analysis of samples synthesized by following the single-stage, 
“one pot” route are shown in Fig. 2(a, b). All the reflections in the XRD patterns match 
those of the HA reference (AMCSD 0009357) [31]. The comparison of crystalline domain 
sizes calculated along different crystallographic directions using Scherrer’s equation 
(Appendix A: Supplementary data, Table A1) shows no signs of significant anisotropy of 
scattering domains.
The highest ratio of crystallite sizes, 3.23, corresponding to reflections (002) and (121), was 
observed in Sample 2, which consisted of highly elongated particles wrapped up in bundles 
(Figs. 3(a) and A1). However, samples denoted as 1, 3 and 4, consisting of bundles of thin 
HA plates (Fig. 3(b), A2(a, b, c), and A3(a, b)), display nearly identical crystallite sizes for 
mutually perpendicular, (002) and (300) reflections. For other samples synthesized using the 
same, “one pot” method, Samples 2 and 5, this ratio was around 2, the reason being lower 
crystallite sizes in the (300) direction in comparison to Samples 1, 3 and 4. This leads to the 
conclusion that crystallites forming bundles in Samples 1, 3 and 4, synthesized at the lowest 
reaction time (20 h), are ordered in the b crystallographic direction. By increasing the 
reaction time to 48 h or 96 h, the bundles disintegrate and 1D HA forms appear, as observed 
for Samples 2 and 5 (Fig. 3(b) and (e); Figs. A1, A2(d) and A3(c)). A considerably lower 
crystallite size than the longest particle dimensions also confirms the polycrystalline nature 
of 1D HA and validates the aggregational growth model now presumed to apply to all forms 
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of HA, be they biological or synthetic. LD particle size distribution parameters, including 
the volumetric mixing proportion (λ), the component median (μ) and the standard deviation 
(σ), are shown in Figs. 3 and A3 for all five samples synthesized using the “one pot” 
method. The difference in the mixing proportion of a component with the smallest median 
diameter (blue color) indicates that the bundles of platelets disintegrate at longer reaction 
times. Only a small fraction of loose particles was detected in Samples 1, 3, and 4, this may 
be due to edges and corrugations on bundled plates rather than to loose particles per se. This 
can explain the difference in μ-s and σ-s of the smallest particle component in these five 
samples.
The formation of plate-like HA structures and their bundles observed in almost all of the 
Samples1 – 5 could not be explained by the dissolution–recrystallization mechanism 
onlybecause the latter would result in hexagonal, far more uniaxially grown structures that 
those evidenced in this case. The crystallization of plate-shaped HA structures thus requires 
the presence of octacalciumphosphate (OCP) as an intermediate phase. OCP has a layered 
structure composed of alternating apatitic and hydrated layers [36–38]. The layered OCP has 
a thin, plate-likemorphology, often resembling ribbons or blades, in contrast to hexagonal 
HA microcrystals, which are usually of needle-shaped character. Yet, the crystal structure of 
the apatitic layers in OCP and HA is remarkably similar [39–43]. The conversion of DCP to 
HAp via OCP can be represented by the following equations:
Intermediately, hydroxyl groups react with hydrogen phosphates within hydrated OCP layers 
to yield phosphates incorporable into the apatite lattice:
In contrast to the dissolution – recrystallization mechanism, here we have a solid-to-solid 
conversion. The result is HA of the characteristic morphology, explaining along the way the 
evolution of delaminated structures observed in all the samples prepared using the “one pot” 
method, especially Samples 1, 3 and 4. The variation of Ca/P ratio and the addition of PVP 
in the ranges and amounts tested in this study (Table 1) had no effects on the morphology. 
The choice of PVP was justified by its prior association with the uniaxial growth of HA 
crystals [44]. The diffractograms and optical micrographs of the one–pot precursor of 
Samples 1 and 2 are shown in Fig. 2(a, b) and Fig. A6(a), respectively. The precursor is 
identified as DCPD (brushite) and exhibits an irregular plate-like morphology. The obvious 
change in the morphology en route from the precursors to the products in the one-pot 
synthesis indicates that the dominant formation mechanism is dissolution – recrystallization. 
Still, solid state conversion could not be excluded as a mechanism of formation of irregular 
plate–like particles in Samples 1 – 5.
The complexity of the transformation mechanisms observed in this system and its relative 
insusceptibility to morphological control called for a more simplistic approach in the 
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synthesis of the desired, 1D morphological structures. The partitioning of synthesis stages 
came out as one of the solutions.
3.2 Two stage synthesis of HA nanowires via DCPA precursor
The first step of this modified, two-stage synthesis procedure (Fig. 1(b)) belongs to the 
synthesis of DCPA precursors via hydrolysis of calcium oleate in a water–ethanol solution. 
Ethanol is used to increase the solubility of calcium oleate, a compound fairly soluble in hot 
ethanol, but practically insoluble in water. The precipitation of DCPA can be described in 
this case with the following reactions:
where OL− is the oleate anion, CH3(CH2)7CH=CH(CH2)7COO−, and OLH is the oleic acid, 
a product of the hydrolysis reaction.
Figure 4 shows XRD patterns of the precursor powders following drying in an oven at 60 °C 
for one day. Interestingly, all powders converted to HA, demonstrating the transient stability 
of DCPA. Micrographs of the precursor powders shown in Fig. 5, most importantly, show 
the lamination of platelets. All the precursor samples contained platelets with a lamellar 
substructure, being the results of the specific growth habit typical for DCPA crystals. Then, 
the (−1 2 0) reflection in the precursor for Sample 7, prepared with the addition of DMF, is 
distinctively more intense than the one in the precursor for Sample 6, prepared using the 
same parameters but excluding DMF. Sample 7 was also synthesized using different 
precursor concentrations so as to investigate the previously suggested influence of DMF on 
crystallization of calcium phosphates [35] and is shown as supplementary data. The 
mechanism for this effect has not been elucidated yet, but has been exploited in “one pot” 
solvothermal syntheses of different 1D and 2D forms of HA [35]. Although the use of DMF 
does induce a structural change in synthesized DCPA, all of the precursors synthesized in its 
presence had the same morphology (Fig. A4). Another effect that plays a crucial role in 
ensuring the growth of regularly shaped platelets comes from oleic complexes as 
Ca2+concentration buffers as well as of oleic anions as agents for the directed, face-specific 
growth. Namely, as the oleic anion, OL−, tends to form a complex bond with Ca2+, crystal 
planes terminated with the largest density of Ca2+ ions will tend to exhibit the largest 
inhibition of growth.
Dried precursors were used for the synthesis of HA Samples 6 and 7, while Sample 8 was 
hydrothermally synthesized using a freshly made and washed, but not dried, precursor 
otherwise identical to that of Sample 7. The difference in the crystallite size between these 
samples, as shown in Table A1, was insignificant. All the samples were identified as HA, 
with only a slight difference in the diffraction peak intensity ratios (Fig. 6).
Morphologically, however, the samples were very different, as seen from the corresponding 
SEM images (Fig. A5). Thus, Sample 6 consists of fine needle–like particles, oftentimes 
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arranged in ladders or woven platelets (Figs. 7 and A5(a)). Sample 7 consists of long wires 
with up to 10 μm in length and around 30 nm in diameter, having the aspect ratio of over 
100:1 (Fig. 8). The morphology of particles comprising Sample 8 is slightly different from 
those found in Sample 6. It is characterized by a small extent of disintegration, the result of 
which are particles with retained plate-like morphology, but with brush-like ends (Fig. A5 
(c)).
Morphological changes associated with the transformation of DCPA to HA were observed 
and discussed in the literature. The predominant transformation, accompanying the 
dehydration of DCPD, is thought to involve the formation of splinters, which then transition 
to nanorods and nanofibers, transforming along the way to HA [23,35], though the one 
involving OCP as the intermediate phase appears to be equally prominent [47]. Both 
mechanisms assume that the preserved morphology of the precursor is due to the similarity 
of the crystal structures of DCPA and OCP to HA. Again, ribbon–like morphologies are 
typically attributable to the transformation via OCP, whereas DCPA tends to dissolve and 
form splinters which regrow into elongated 1D shapes and eventually rearrange into 
hierarchically ordered structures. In this study we have come up with a clear evidence of the 
effect that the structural changes of DCPA precursors have on the morphology of the 
resulting HA particles. Under all the conditions tested for the hydrothermal transformation 
of DCPA into 1D HA structures, the complete conversion of shapes occurredin one case 
only (Sample 7).
The mechanism for the formation of uniform 1D HA structures is dissolution/
recrystallization, kinetically limited and controlled by the gradual solubility of DCPA as the 
intermediate and the source of ions for the growth HA. Whereas abrupt increases in 
supersaturation favor the formation of rounded and smaller particles, slow increases in 
supersaturation favor the elongation of HA crystals, alongside excluding the epitaxial growth 
of HA on an OCP template in the form of plates [21]. Urea decomposition is one factor 
enabling the slow release of a constitutive ion, OH−, and its concentration can be tuned by 
controlling the temperature of the hydrothermal treatment, i.e. temperature at which urea 
decomposes. Another factor, equally critical, is the intermediate dissolution of DCPA. For 
example, if the surface of DCP is blocked with oleic species, the dissolution is hindered and 
non-uniform growth results. The precise coupling of the two simultaneously occurring 
processes - dissolution/recrystalization and solid–to–solid conversion – appears to be crucial 
in order to obtain elongated and uniform morphologies. The presence of OCP, that occurs as 
an intermediary in the one-pot synthesis, can be used as an indicator that the transformation 
of DCP to HA is not direct enough and not optimized to yield 1D structures. Thus we 
believe that controlling the concentration of OH− ions throughout the growth process in a 
specific, relatively narrow range is a key factor in favor of the growth of 1D structures. It can 
be tuned by controlling the temperature of the hydrothermal process (mainly in lower and 
mild temperature ranges) and the amount of urea as the source of OH− ions.
3.3 FTIR analysis of precursors and samples
The FTIR spectra of the DCPD precursor for Samples 1 and 2, of Ca oleate complex, and of 
the DCPA precursors for Samples 6 – 8, along with the corresponding final products, are 
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shown in Fig. 9. Based on the FTIR spectrum of the one-pot synthesis precursor, Fig. 9(a), it 
is identified as pure DCPD [48,49] (purple line). The spectra of precursors used in the 
second, two-stage synthetic approach (Samples 6 – 8) are identified as DCPA (green and 
black lines) and are shown along with the IR spectrum of calcium oleate complex (blue 
line). The prominent bands at 2923 cm−1 and 2852 cm−1 correspond to the asymmetric and 
symmetric stretch of -CH2- groups. The characteristic doublet at 1577 cm−1 and 1541 cm−1, 
together with the bands at 1467 cm−1 and 1429 cm−1, is assigned to the asymmetric and 
symmetric stretch of -COO− groups [50,51]. The given bands are characteristic for calcium 
oleate (calcium dioleate) complex. The DCPA precursors have characteristic bands 
originating from P-O- and P-O-H bonds at 1131 cm−1, 1067 cm−1, 902 cm−1, 578 cm−1 and 
530 cm−1. The band at 1637 cm−1 results from the H-O-H bending and rotation of the 
residual water, while bands at 2923 cm−1 and 2852 cm−1 are attributed to –CH2– groups 
from oleate anions adsorbed on the surface of monetite. Distinct bands arise in the precursor 
of Sample 6, specifically at 1707 cm−1 and 1736 cm−1, corresponding to adsorbed oleic acid 
dimer and monomer, respectively [52]. This specific band does not exist in the spectrum of 
the precursor for Samples 7 and 8. This might be the effect of hydrolysis of oleate at lower 
pH values during the reaction to which DMF is not added. The addition of DMF raises pH of 
the reaction medium and prevents the hydrolysis of oleate anion and its conversion to oleic 
acid [53]. FTIR spectra of HA samples contain all four characteristic apatite phosphate 
vibration modes with bands at 1094 cm−1, 1031 cm−1, 961 cm−1, 602 cm−1 and 564 cm−1 
[54].
From these characterization data, we can conclude that two key factors play a role in 
determining the final morphology of HA samples synthesized using the two-stage method. 
The first is the adsorption of oleic species and the second is the drying of the freshly 
synthesized precursor. In the case of the adsorption of oleic acid, presumably in bilayers, as 
we assume it occurs on the DMF-free precursor of Sample 6, it must entail a significant 
change of surface hydrophilicity. Specifically, the surface becomes more hydrophobic, 
which slows down the kinetics of dissolution. Sample 6 is morphologically different from 
Sample 8, in a way that platelets appear more disintegrated, albeit not fully. Dissolution was 
more intense than in Sample 8, but less than in Sample 7. The formation of HA nanowires 
observed in all three samples can be attributed to the presence of oleate ion, which is capable 
of binding more intensely to Ca2+ on the surface of HA;this would explain the more directed 
and uniaxial growth of HA. As for the second effect, the drying of the precursor, we believe 
that low temperature transformation, physical or chemical, may occur, e.g., dehydration of 
DCPD to DCPA and/or desorption of oleate species. One must notice that the characterized 
precursors were dried at 60 °C for 24 h. Sample 8 is prepared using a freshly synthesized 
precursor without the drying step during which we believe the solid–to–solid chemical 
reaction is promoted; as a result, the plate-like morphology is being predominantly retained. 
These intermediate processes, alongside other key aspects of this phase transformation, must 
be investigated in more detail in the design of HA micro- and nano-structures with advanced 
therapeutic potentials.
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3.4 In vitro study of synthesized DCPA platelets and HA nanowires
Cytotoxicity and biocompatibility of DCPA platelets as precursorsfor HA nanowires 
comprising Sample 7, as well as of the given HA nanowires, were examined in vitro, in 
osteoblastic MC3T3-E1 cell culture. The MTT assay measures the mitochondrial succinic 
dehydrogenase activity and is a strong indicator of cytotoxic effects affecting cell viability. 
Elongated particle morphologies are often associated with increased cytotoxicity, even for 
compositions for which round particle shapes have no adverse effects on cells. Although 
tremolite [55] and other asbestoses [56] are paradigmatic examples in favor of this effect, the 
latter has been observed for multiple other particle compositions, ranging from titania [57] 
to carbon nanotubes [58] to ceria [59]. Moreover, compared to spherical HA nanoparticles, 
needle-shaped ones induced a considerably higher cytotoxicity and inflammatory cytokines 
production in BEAS-2B and RAW264.7 cells than the spherical ones [60]. Apoptosis 
mediated by a mitochondrial-dependent pathway in primary rat osteoblasts was also 
noticeably increased following incubation with needle-shaped HA particles as opposed to 
the spherical ones [61]. Such apoptotic effects observedin HepG2 cells were the basis for 
proposing HA as utilizable in the treatment of hepatoma and other types of cancer [62]. 
Needle-shaped HA also slowed down the cell metabolism and inhibited hatching in catfish 
T-cells and zebrafish embryos in a dose-dependent manner [63]. Other studies suggested 
good biocompatibility and a lack of cytotoxic effects of needle-shaped HA when tested in 
vitro [64,65], demonstrating a great degree of variability of the biological response to such 
morphologies. The exact amount, shape, texture, aspect ratio, surface charge, agglomeration 
degree, the dosage mode (seeding cells onto the powder, depositing powder on top of the 
cells or co-seeding), the cell type and the interaction of the particles with biomolecules 
contained in the growth medium are all factors influencing the biological response to them, 
needing further studies to be discerned and analyzed. As seen in Fig. 10, no decrease in cell 
viability was observed for any of the three calcium phosphate samples (spherical HA 
standard, needle-shaped HA comprising Sample 7, and DCPA as the precursor for Sample 7) 
in comparison with the particle-free control. The only significant difference in viability was 
observed for the spherical HA nanoparticle standard synthesized using a previously reported 
protocol [66]: cells incubated with this powder demonstrated a higher viability compared to 
the control, particle-free cell population, albeit only at the lower of the two tested particle 
concentrations (Fig. 10). Also, the elongated HA particles comprising Sample 7 did not 
cause any significant change in cell viability compared to the spherical HA nanoparticle 
standard at either of the two particle concentrations. These results corroborate our previous 
finding of no markedly negative effects on osteoblastic cells exerted by elongated particles 
of DCPA synthesized in an urea-assisted precipitation process except for the mild 
granulations of the cytoskeletal microfilaments [67]. In spite of the dosage amount 
exceeding fifty times that for which apoptotic effects were observed in osteoblasts in an 
earlier study [61] (0.02 – 1 vs. 1 – 5 mg/ml), no inhibitory effects or cellular injury were 
detected for 1D HA fabricated in this study.
Concordantly, immunofluorescent images shown in Fig. 11 demonstrate a favorable particle/
cell interface for both the DCPA precursor and the final product, HA, of Sample 7. 
Cytoskeletal f-actin microfilaments display a continuous, uninterrupted structure, devoid of 
aggregations, signifying a healthy internal structure and morphology of the cells in contact 
Stojanović et al. Page 11
Mater Sci Eng C Mater Biol Appl. Author manuscript; available in PMC 2017 November 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
with the particles. No difference between the control, particle-free cell populations and those 
incubated with these two types of elongated particles of calcium phosphate was observed.
4. Conclusion
In summary, we designed a two-stage process for the high-yield synthesis of 1D HA 
nanostructures with diameters on the nano scale and aspect ratios exceeding 100:1. 
Optimization of the DCP precursor for the hydrothermal synthesis is required for its 
transformation to 1D HA to reach completion. To achieve a better control over particle size 
and morphology, the first stage of the process, involving the synthesis of DCP, must be 
investigated in more detail. Understanding the effect of various hydrothermal processing 
parameters, to which this study has contributed, will help in gaining a better control over this 
process and making it more suitable for the application as a method for the high-yield 
synthesis of various other 1D HA micro- and nano-structures. In vitro studies on osteoblastic 
cells demonstrated the absence of any cytotoxic effects caused by the particles and a very 
high level of biocompatibility, indicating a pronouncedly promising potential of these HA 
systems for biomedical applications.
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Appendix A. Supplementary data
Tables showing crystallite sizes of samples 1 – 8; SEM images accompanied with particle 
size distribution from laser diffraction; optical microscopy images of precursors and 
samples; and R markdown file showing the code for decomposition of mixed distributions 
applied on XRD data and size distribution data.
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Highlights
• novel hydrothermal synthesis of HA nanowires
• controlled synthesis of 1D and 2D morphologies
• high level of biocompatibility of nanowires
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Figure 1. 
The sketch of “one-pot” route for the synthesis of 1D HAstructures (a), and the two-stage 
1D HA synthesis route via DCP platelets (b).
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Figure 2. 
XRD patterns of precursor for samples 1 and 2 and for samples from 1 to 5 within the whole 
2Θ measurement range (a) and with a zoom on a selected interval (b). The diffractograms 
are compared to the reflections of the reference AMCSD code 0008880 and code 0009357 
corresponding to DCPD (brushite) and pure HA, respectively.
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Figure 3. 
SEM images of 1D HA along with the particle size distributions for Samples 2 (a) and 4 (b), 
including the mixing proportion and other parameters for the convoluted components of the 
distributions. The μ-s and σ-s are given in microns. Scale bars are a) 50 and 10 μm and b) 50 
and 5 μm respectively.
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Figure 4. 
XRD patterns of the precursors for the hydrothermal synthesis of HA following the second, 
two-step route (a) for the whole 2Θ measurement range and (b) with a zoom on a selected 
interval. The star (*) denotes an unidentified impurity in sample 6 (b). The patterns are 
compared with the reference cards for brushite – DCPD code no. 0008880 [45] and monetite 
– DCPA code no. 0009584 [46].
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Figure 5. 
SEM and TEM images of platelets as precursors for the hydrothermal synthesis of Samples 
6 (a) (scale bars 1 μm and 500 nm) and 7 (b) (scale bars 1 μm, 500 nm and 200 nm), 
revealing laminated microstructure.
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Figure 6. 
XRD patterns of Samples 6, 7 and 8 compared to the reference AMCSD code 0009357 
corresponding to pure HA.
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Figure 7. 
FE-SEM, TEM images and electron diffractions of Samples 6 (a) (scale bars 200 nm) and 7 
(b) (scale bars 200 and 50 nm). SAED patterns are identified as HA reflections.
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Figure 8. 
Distribution of the diameters and lengths of HA nanowires comprising Sample 7, resulting 
from the comparative analysis of several TEM and optical microscopy images. The mean 
diameter and length of HA nanowires are 37 nm and 3.7 microns respecively.
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Figure 9. 
FTIR spectra of precursors for the hydrothermal synthesis of HA (a) and of the products 
(Samples 2, 6, 7, 8) (b).
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Figure 10. 
MTT assay absorbance indicative of the viability ofosteoblastic MC3T3-E1 cells incubated 
with various calcium phosphate powders at the concentrations of 0.5 and 2.6 mg/cm2 (1 and 
5 mg per well and per ml of media in the standard 24-well plate, respectively). All the data 
are represented as averages of three independent cell/particle analyses. Error bars represent 
the standard deviation (for Sample 7 HA at 5 mg/ml it is invisible to the eye). Data points 
significantly different from the “cell only” control (p < 0.05) are marked with an asterisk.
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Figure 11. 
Confocal optical micrographs of MC3T3-E1 cells incubated either with identical amounts (5 
mg/well) of Sample 7 HA particles (a) or Sample 7 precursor DCPA particles (b) and 
culturedfor 7 days. Green – calcium phosphate particles; blue – MC3T3-E1 cell nuclei; red – 
f-actin cytoskeletal microfilaments.
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Table 2
Parameters describing the synthesis of 1D HA structures in the two-stage process
Sample6 Sample7 Sample8
Precursor synthesis
Ca/P 0.5 0.5 0.5
DMF none 100 ml 100 ml
Drying yes yes no
Hydrothermal synthesis
Time (h) 72 72 72
pH after the hydrothermal reaction 10 10 10
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